Spc Copay



TRIKAFTA is a breakthrough treatment for people with CF age 12
years and older with at least one copy of the F508del mutation or
at least one other responsive mutation.

  1. Spc Company Limited
  2. Spc Copay
Spc Copay

CF will always be part of the equation, but you know there's more
to who you are.

Make TRIKAFTA part of your equation—a triple combination
therapy that treats the underlying cause.

Spc

$20 copay PCP/ $70 copay SPC; deductible does not apply and 25% coinsurance for other outpatient services Not Covered None Habilitation services $20 copay PCP/ $70 copay SPC; deductible does not apply and 25% coinsurance for other outpatient services Not Covered Skilled nursing care 25% coinsurance Not Covered. $40 PCP / $50 SPC copay/visit; deductible does not apply 30% coinsurance Copay applies to first prenatal visit (per pregnancy). Cost sharing does not apply for preventive services. Depending on the type of services, a copayment, coinsurance, or deductible may apply. Maternity care may include tests. SPC Copay (BCO/ PPO OON) Coins OPX (BCO /PPO/ OON) (BCO/ ER Copay Urgent Care Copay Non-Preferred Pharmacy. Silver S507OPT $0-$50 $4000/ $4750/ $9500.

TRIKAFTA is a breakthrough
treatment for people with CF age
12 years and older with at least
one copy of the F508del mutation
or at least one other responsive mutation.

CF will always be part of the equation,
but you know there's more
to who you are.

Make TRIKAFTA part of your equation—a triple combination
therapy that treats the underlying cause.

F508del/F508del

People with CF pictured may or may not be taking TRIKAFTA.

Based on the information entered, you may be eligible for TRIKAFTA.

Talk with your healthcare provider to see if TRIKAFTA is right for you.

Here is some information about TRIKAFTA that may be helpful:

Neither CF gene mutation you entered is eligible for TRIKAFTA.

Spc Company Limited

Talk with your healthcare provider to discuss your CF care plan and treatment options that may be right for you.

You can view the list of eligible mutations here.

Get answers to common questions, such as:

  • How does TRIKAFTA work?

  • What are the study details and results?

  • What are the possible side effects?

Get to Know Vertex GPS™:!break Guidance & Patient Support

Vertex GPS offers eligible patients ongoing one-on-one support, right from the start of treatment. Patient Support Specialists can help you navigate questions about insurance, reimbursement, and potential co-pay assistance. You can even get tips for your Vertex treatment and resources that may help you stay on track. No matter where you’re headed, Vertex GPS is with you along the way.

What is Retevmo?

Retevmo is a prescription medicine that is used to treat certain cancers caused by abnormal RET genes in adults with non-small cell lung cancer (NSCLC) that has spread, adults and children 12 years of age and older with advanced medullary thyroid cancer (MTC) or MTC that has spread who require a medicine by mouth or injection (systemic therapy), and adults and children 12 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy) and who have received radioactive iodine and it did not work or is no longer working.

Your healthcare provider will perform a test to make sure that Retevmo is right for you. It is not known if Retevmo is safe and effective in children younger than 12 years of age.

Spc Copay

Retevmo was approved based on the percentage of patients whose tumor size shrank or disappeared after treatment and how long the response lasted. Studies are ongoing to confirm the benefit of Retevmo for this use.

Retevmo may affect both healthy cells and tumor cells, which can result in side effects, some of which can be serious.

Spc company limited

Retevmo is a targeted cancer therapy; it is not chemotherapy.